BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27419275)

  • 1. A Novel NOD2-associated Mutation and Variant Blau Syndrome: Phenotype and Molecular Analysis.
    Ebrahimiadib N; Samra KA; Domina AM; Stiles ER; Ewer R; Bocian CP; Foster CS
    Ocul Immunol Inflamm; 2018; 26(1):57-64. PubMed ID: 27419275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome).
    Carreño E; Guly CM; Chilov M; Hinchcliffe A; Arostegui JI; Lee RW; Dick AD; Ramanan AV
    Acta Ophthalmol; 2015 May; 93(3):253-7. PubMed ID: 25209167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation in early-onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes.
    Okazaki F; Wakiguchi H; Korenaga Y; Nakamura T; Yasudo H; Uchi S; Yanai R; Asano N; Hoshii Y; Tanabe T; Izawa K; Honda Y; Nishikomori R; Uchida K; Eishi Y; Ohga S; Hasegawa S
    Pediatr Rheumatol Online J; 2021 Feb; 19(1):18. PubMed ID: 33602264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Pathogenic
    Rodrigues FG; Petrushkin H; Webster AR; Bickerstaff M; Moraitis E; Rowczenio D; Aróstegui JI; Westcott M
    Ophthalmic Genet; 2021 Dec; 42(6):753-764. PubMed ID: 34251956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel nucleotide oligomerisation domain 2 mutation in a family with Blau syndrome: Phenotype and function.
    Ong LT; Nachbur U; Rowczenio D; Ziegler JB; Fischer E; Lin MW
    Innate Immun; 2017 Oct; 23(7):578-583. PubMed ID: 28836875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.
    Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP
    J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Mutation in Helical Domain 2 of NOD2 in Sporadic Blau Syndrome.
    Jain L; Gupta N; Reddy MM; Mittal R; Barik MR; Panigrahi B; Monie T; Basu S
    Ocul Immunol Inflamm; 2018; 26(2):292-294. PubMed ID: 27625029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveitis in Blau syndrome from a de novo mutation of the NOD2/CARD15 gene.
    Raiji VR; Miller MM; Jung LK
    J AAPOS; 2011 Apr; 15(2):205-7. PubMed ID: 21596301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blau syndrome with a rare mutation in exon 9 of
    Velickovic J; Silan F; Bir FD; Silan C; Albuz B; Ozdemir O
    Autoimmunity; 2019; 52(7-8):256-263. PubMed ID: 31556326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulomatous skin involvement in a patient with an unusual NOD2 mutation.
    Kuye IO; Adisa M; Nazarian RM; Arvikar SL; Smith GP
    Australas J Dermatol; 2017 May; 58(2):142-144. PubMed ID: 26768519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
    Mao L; Dhar A; Meng G; Fuss I; Montgomery-Recht K; Yang Z; Xu Q; Kitani A; Strober W
    Front Immunol; 2022; 13():988862. PubMed ID: 36189261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Blau syndrome without uveitis caused by a novel mutation in the nucleotide-binding oligomerization domain-containing protein 2 gene with good response to infliximab.
    Toral-López J; González-Huerta LM; Martín-Del Campo M; Messina-Baas O; Cuevas-Covarrubias SA
    Pediatr Dermatol; 2018 May; 35(3):e180-e183. PubMed ID: 29570830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: First Identification of Intrafamilial Recurrence of Blau Syndrome due to Gonosomal NOD2 Mosaicism.
    Mensa-Vilaro A; Cham WT; Tang SP; Lim SC; González-Roca E; Ruiz-Ortiz E; Ariffin R; Yagüe J; Aróstegui JI
    Arthritis Rheumatol; 2016 Apr; 68(4):1039-44. PubMed ID: 26606664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Blau syndrome:First molecularly confirmed report from India.
    Janarthanan M; Poddar C; Sudharshan S; Seabra L; Crow YJ
    Indian J Ophthalmol; 2019 Jan; 67(1):165-167. PubMed ID: 30574935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular Features in Chinese Patients with Blau Syndrome.
    Wu S; Zhong L; Sun Z; Zhu T; Song H; Sui R
    Ocul Immunol Inflamm; 2020; 28(1):79-85. PubMed ID: 30806112
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the
    Matsuda T; Kambe N; Ueki Y; Kanazawa N; Izawa K; Honda Y; Kawakami A; Takei S; Tonomura K; Inoue M; Kobayashi H; Okafuji I; Sakurai Y; Kato N; Maruyama Y; Inoue Y; Otsubo Y; Makino T; Okada S; Kobayashi I; Yashiro M; Ito S; Fujii H; Kondo Y; Okamoto N; Ito S; Iwata N; Kaneko U; Doi M; Hosokawa J; Ohara O; Saito MK; Nishikomori R; ;
    Ann Rheum Dis; 2020 Nov; 79(11):1492-1499. PubMed ID: 32647028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipogranulomatous subconjunctival nodules: a novel presentation in Blau syndrome.
    Ahmad M; Hermanson ME; Enzenauer R; Palestine A; Lin C; Meeks N; McCourt E
    J AAPOS; 2017 Jun; 21(3):249-251. PubMed ID: 28532706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blau Syndrome: A Systemic Granulomatous Disease of Cutaneous Onset and Phenotypic Complexity.
    Rose CD
    Pediatr Dermatol; 2017 Mar; 34(2):216-218. PubMed ID: 27874205
    [No Abstract]   [Full Text] [Related]  

  • 19. Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation.
    Kurokawa T; Kikuchi T; Ohta K; Imai H; Yoshimura N
    Ophthalmology; 2003 Oct; 110(10):2040-4. PubMed ID: 14522785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blau-Jabs Syndrome in a Tertiary Ophthalmologic Center.
    Nascimento H; Sousa JM; Fernández DG; Salomão GHA; Sato EH; Muccioli C; Belfort R
    Ophthalmic Surg Lasers Imaging Retina; 2018 Jan; 49(1):70-75. PubMed ID: 29304271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.